CA2894317C - Systemes et methodes de classement, priorisation et interpretation de variants genetiques et therapies employant un reseau neuronal profond - Google Patents
Systemes et methodes de classement, priorisation et interpretation de variants genetiques et therapies employant un reseau neuronal profond Download PDFInfo
- Publication number
- CA2894317C CA2894317C CA2894317A CA2894317A CA2894317C CA 2894317 C CA2894317 C CA 2894317C CA 2894317 A CA2894317 A CA 2894317A CA 2894317 A CA2894317 A CA 2894317A CA 2894317 C CA2894317 C CA 2894317C
- Authority
- CA
- Canada
- Prior art keywords
- variant
- condition
- specific
- sequence
- dna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/20—Supervised data analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
- G16B5/20—Probabilistic models
Landscapes
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Theoretical Computer Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Evolutionary Biology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Data Mining & Analysis (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Public Health (AREA)
- Software Systems (AREA)
- Evolutionary Computation (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Artificial Intelligence (AREA)
- Bioethics (AREA)
- Databases & Information Systems (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Probability & Statistics with Applications (AREA)
- Physiology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Il est décrit des systèmes et procédés qui reçoivent, comme entrée, une séquence dacide désoxyribonucléique (ADN) ou dacide ribonucléique, extraient des caractéristiques, et appliquent des couches dunités de traitement afin de calculer au moins une variable de cellule propre à une condition, correspondant à des quantités cellulaires mesurées dans différentes conditions. Le système pourrait sappliquer à une séquence contenant une variante génétique, ainsi quà une séquence de référence correspondante, afin de déterminer jusquà quel point les variables de cellule propres à une condition changent en raison de la variante. Le changement dans les variables de cellule propres à une condition est utilisé pour calculer un score représentant jusquà quel point la variante est nuisible, pour classer le niveau de caractère nuisible dune variante, pour établir des variantes aux fins de traitement subséquent, et pour comparer une variante de test à des variantes délétères connues. En modifiant la variante ou les caractéristiques extraites pour intégrer les effets de modification dADN, de thérapie doligonucléotide, de thérapie de liaison de protéine dADN ou dacide ribonucléique, ou dautres thérapies, le système peut être utilisé pour déterminer sil est possible de réduire les effets nuisibles de la variante originale.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2894317A CA2894317C (fr) | 2015-06-15 | 2015-06-15 | Systemes et methodes de classement, priorisation et interpretation de variants genetiques et therapies employant un reseau neuronal profond |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2894317A CA2894317C (fr) | 2015-06-15 | 2015-06-15 | Systemes et methodes de classement, priorisation et interpretation de variants genetiques et therapies employant un reseau neuronal profond |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2894317A1 CA2894317A1 (fr) | 2016-12-15 |
CA2894317C true CA2894317C (fr) | 2023-08-15 |
Family
ID=57543744
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2894317A Active CA2894317C (fr) | 2015-06-15 | 2015-06-15 | Systemes et methodes de classement, priorisation et interpretation de variants genetiques et therapies employant un reseau neuronal profond |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2894317C (fr) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108229523B (zh) * | 2017-04-13 | 2021-04-06 | 深圳市商汤科技有限公司 | 图像检测、神经网络训练方法、装置和电子设备 |
US20200234137A1 (en) * | 2017-08-18 | 2020-07-23 | Intel Corporation | Efficient neural networks with elaborate matrix structures in machine learning environments |
KR102416048B1 (ko) * | 2017-10-16 | 2022-07-04 | 일루미나, 인코포레이티드 | 변이체 분류를 위한 심층 컨볼루션 신경망 |
SG11201912745WA (en) | 2017-10-16 | 2020-01-30 | Illumina Inc | Deep learning-based splice site classification |
US11861491B2 (en) | 2017-10-16 | 2024-01-02 | Illumina, Inc. | Deep learning-based pathogenicity classifier for promoter single nucleotide variants (pSNVs) |
WO2019136376A1 (fr) | 2018-01-08 | 2019-07-11 | Illumina, Inc. | Séquençage à haut débit à détection à semi-conducteur |
KR102239487B1 (ko) | 2018-01-08 | 2021-04-14 | 일루미나, 인코포레이티드 | 반도체-기반 검출을 사용한 고-처리율 서열분석 |
AU2019206709B2 (en) * | 2018-01-15 | 2021-09-09 | Illumina Cambridge Limited | Deep learning-based variant classifier |
CN108680861B (zh) * | 2018-03-05 | 2021-01-01 | 北京航空航天大学 | 锂电池剩余循环寿命预测模型的构建方法及装置 |
CN110362807A (zh) * | 2018-03-26 | 2019-10-22 | 中国科学院信息工程研究所 | 基于自编码器的变体词识别方法及系统 |
WO2019200338A1 (fr) * | 2018-04-12 | 2019-10-17 | Illumina, Inc. | Classificateur de variantes basé sur des réseaux neuronaux profonds |
NL2020861B1 (en) * | 2018-04-12 | 2019-10-22 | Illumina Inc | Variant classifier based on deep neural networks |
WO2019222120A1 (fr) * | 2018-05-14 | 2019-11-21 | Quantum-Si Incorporated | Ensemble polymère biologique activé par apprentissage automatique |
WO2020041204A1 (fr) | 2018-08-18 | 2020-02-27 | Sf17 Therapeutics, Inc. | Analyse d'intelligence artificielle de transcriptome d'arn pour la découverte de médicament |
US11443832B2 (en) | 2019-03-07 | 2022-09-13 | Nvidia Corporation | Genetic mutation detection using deep learning |
US11842794B2 (en) | 2019-03-19 | 2023-12-12 | The University Of Hong Kong | Variant calling in single molecule sequencing using a convolutional neural network |
US11347965B2 (en) | 2019-03-21 | 2022-05-31 | Illumina, Inc. | Training data generation for artificial intelligence-based sequencing |
US11210554B2 (en) | 2019-03-21 | 2021-12-28 | Illumina, Inc. | Artificial intelligence-based generation of sequencing metadata |
US11593649B2 (en) | 2019-05-16 | 2023-02-28 | Illumina, Inc. | Base calling using convolutions |
WO2021168353A2 (fr) | 2020-02-20 | 2021-08-26 | Illumina, Inc. | Appel de base de plusieurs à plusieurs basé sur l'intelligence artificielle |
US11830606B2 (en) * | 2020-04-28 | 2023-11-28 | Siemens Healthcare Gmbh | Risk prediction for COVID-19 patient management |
CN113810335B (zh) * | 2020-06-12 | 2023-08-22 | 武汉斗鱼鱼乐网络科技有限公司 | 一种识别目标ip的方法及系统、存储介质、设备 |
CN112017771B (zh) * | 2020-08-31 | 2024-02-27 | 吾征智能技术(北京)有限公司 | 一种基于精液常规检查数据的疾病预测模型的构建方法及系统 |
US20220336054A1 (en) | 2021-04-15 | 2022-10-20 | Illumina, Inc. | Deep Convolutional Neural Networks to Predict Variant Pathogenicity using Three-Dimensional (3D) Protein Structures |
CN114360652B (zh) * | 2022-01-28 | 2023-04-28 | 深圳太力生物技术有限责任公司 | 细胞株相似性评价方法及相似细胞株培养基配方推荐方法 |
CN116798521B (zh) * | 2023-07-19 | 2024-02-23 | 广东美赛尔细胞生物科技有限公司 | 免疫细胞培养控制系统的异常监测方法及系统 |
-
2015
- 2015-06-15 CA CA2894317A patent/CA2894317C/fr active Active
Also Published As
Publication number | Publication date |
---|---|
CA2894317A1 (fr) | 2016-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11887696B2 (en) | Systems and methods for classifying, prioritizing and interpreting genetic variants and therapies using a deep neural network | |
CA2894317C (fr) | Systemes et methodes de classement, priorisation et interpretation de variants genetiques et therapies employant un reseau neuronal profond | |
Chen et al. | Hidden bias in the DUD-E dataset leads to misleading performance of deep learning in structure-based virtual screening | |
Rifaioglu et al. | MDeePred: novel multi-channel protein featurization for deep learning-based binding affinity prediction in drug discovery | |
Lai et al. | Artificial intelligence and machine learning in bioinformatics | |
Zou et al. | Approaches for recognizing disease genes based on network | |
Zhang et al. | Discerning novel splice junctions derived from RNA-seq alignment: a deep learning approach | |
US8572018B2 (en) | Method, system and software arrangement for reconstructing formal descriptive models of processes from functional/modal data using suitable ontology | |
Huang et al. | Machine learning applications for therapeutic tasks with genomics data | |
Nardini et al. | Learning equations from biological data with limited time samples | |
Handl et al. | Weighted elastic net for unsupervised domain adaptation with application to age prediction from DNA methylation data | |
Deng et al. | Massive single-cell RNA-seq analysis and imputation via deep learning | |
Conard et al. | A spectrum of explainable and interpretable machine learning approaches for genomic studies | |
Buettner et al. | Scalable latent-factor models applied to single-cell RNA-seq data separate biological drivers from confounding effects | |
Wang et al. | Lm-gvp: A generalizable deep learning framework for protein property prediction from sequence and structure | |
Linghu et al. | Construction of functional linkage gene networks by data integration | |
Pe'er | From gene expression to molecular pathways | |
Amilpur et al. | A sequence-based two-layer predictor for identifying enhancers and their strength through enhanced feature extraction | |
van Hilten et al. | Phenotype prediction using biologically interpretable neural networks on multi-cohort multi-omics data | |
Gu | Applying Machine Learning Algorithms for the Analysis of Biological Sequences and Medical Records | |
Kabir et al. | DRBpred: A sequence-based machine learning method to effectively predict DNA-and RNA-binding residues | |
Slawek | Inferring gene regulatory networks from expression data using ensemble methods | |
Brenerman et al. | Random Forest Factorization Reveals Latent Structure in Single Cell RNA Sequencing Data | |
Sauta | A data fusion approach for learning transcriptional Bayesian networks in chronic leukemia | |
Assefa | Statistical methods for testing differential gene expression in bulk and single-cell RNA sequencing data |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |
Effective date: 20200609 |
|
EEER | Examination request |
Effective date: 20200609 |
|
EEER | Examination request |
Effective date: 20200609 |
|
EEER | Examination request |
Effective date: 20200609 |
|
EEER | Examination request |
Effective date: 20200609 |
|
EEER | Examination request |
Effective date: 20200609 |
|
EEER | Examination request |
Effective date: 20200609 |
|
EEER | Examination request |
Effective date: 20200609 |
|
EEER | Examination request |
Effective date: 20200609 |
|
EEER | Examination request |
Effective date: 20200609 |